Print Issue: September 01, 2008

PD Patient Survival Better—At First

LONDON, Ont.—Patients on peritoneal dialysis (PD) live longer than those on hemodialysis (HD), at least during the first years after dialysis starts, a new study suggests. A question remains, however, whether it is the type of dialysis that makes the difference in survival.

Urine Test Detects Upper Tract TCC

With upper tract transitional cell carcinoma (UTTCC), vigilance is the watchword. Detecting this cancer earlier may directly impact patient survival. According to the American Cancer Society, 54,390 new cases and 14,100 deaths in the United States will occur during 2008.

Prognostic Claim with Resubmission of PSA Test Application

IRIS International, Inc., of Chatsworth, Calif., after extensive consultation with the FDA, plans to resubmit its 510(k) application for the company’s NADiA PSA ultrasensitive diagnostic test with a prognostic claim for identifying post-prostatectomy patients at low risk of prostate cancer recurrence.

Investors Who Make a Bad Time Worse

IN A year when the Standard & Poor’s 500-stock index has been dropping, the average mutual fund investor should do even worse than the benchmark, says Louis Harvey, president of Dalbar, a Boston research firm. The problem is that millions of investors have panicked.

Funds That Lead When Stocks Fall

During the first six months of 2008, the Standard & Poor’s 500-stock index lost 12%, and most equity mutual funds suffered double-digit declines. Long-short funds were among the few that avoided losses. These resilient choices have proven their ability to make money in up years and down.

Next post in Your Money